Literature DB >> 3485824

Regional location of alpha 1-antichymotrypsin and alpha 1-antitrypsin genes on human chromosome 14.

M Rabin, M Watson, V Kidd, S L Woo, W R Breg, F H Ruddle.   

Abstract

The human protease inhibitor genes alpha 1 antitrypsin (alpha 1-PI) and alpha 1-antichymotrypsin (alpha 1-ACT) are acute-phase proteins which are induced in response to inflammation. These inhibitors function to limit the activity of serine proteases in vivo. alpha 1-PI acts as an inhibitor of neutrophil elastase to protect the elastin fibers of the lung. Genetic deficiencies of alpha 1-PI result in development of chronic pulmonary emphysema. The physiologic role of alpha 1-ACT has not been clearly defined, but it also appears to function in the maintenance of protease-protease inhibitor equilibrium in the lung. Nucleic acid and protein sequence homologies detected between alpha 1-PI and alpha 1-ACT suggested an evolutionary relationship. Gene mapping experiments were performed to determine if these protease inhibitor genes reside at the same chromosomal locus in man. In situ hybridization data demonstrate that both alpha 1-PI and alpha 1-ACT map to the same region, q31-q32.3, on chromosome 14.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485824     DOI: 10.1007/BF01560668

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  18 in total

1.  Comparative properties of three functionally different but structurally related serpin variants from horse plasma.

Authors:  J Potempa; J K Wunderlich; J Travis
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

Review 2.  Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders.

Authors:  H Potter
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

3.  Distal trisomy 14q. II. Molecular study of the 14q32 locus in two cases of chromosome 14 rearrangements with partial duplication.

Authors:  G Keyeux; S Gilgenkrantz; G Lefranc; M P Lefranc
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

4.  Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele.

Authors:  T Nukiwa; M L Brantly; F Ogushi; G A Fells; R G Crystal
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

5.  Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.

Authors:  D Curiel; M Brantly; E Curiel; L Stier; R G Crystal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Characterization of the normal alpha 1-antitrypsin allele Vmunich: a variant associated with a unique protein isoelectric focusing pattern.

Authors:  M D Holmes; M L Brantly; D T Curiel; S Weidinger; R G Crystal
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

7.  Differential regulation of gene activity and chromatin structure within the human serpin gene cluster at 14q32.1 in macrophage microcell hybrids.

Authors:  P Rollini; R E Fournier
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

8.  Deoxyribonucleic acid (DNA) polymorphism of the alpha 1-antitrypsin gene in chronic lung disease.

Authors:  N A Kalsheker; I J Hodgson; G L Watkins; J P White; H M Morrison; R A Stockley
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

9.  Cloning of the human alpha 1 antichymotrypsin gene and genetic analysis of the gene in relation to alpha 1 antitrypsin deficiency.

Authors:  G D Kelsey; D Abeliovich; C J McMahon; D Whitehouse; G Corney; S Povey; D A Hopkinson; J Wolfe; G Mieli-Vergani; A P Mowat
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318

10.  Array CGH defined interstitial deletion on chromosome 14: a new case.

Authors:  Maria Piccione; Vincenzo Antona; Valeria Scavone; Michela Malacarne; Mauro Pierluigi; Marina Grasso; Giovanni Corsello
Journal:  Eur J Pediatr       Date:  2010-01-21       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.